Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Safety, Tolerability, Pharmacokinetic, Food Effect, and Proof-of-Concept Study of Single and Multiple Doses of ORX489 in Healthy Adults

NCT07413666 is registered in ClinicalTrials.gov with Centessa Pharmaceuticals (UK) Limited as lead sponsor.

NCT NCT07413666
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07413666 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Safety, Tolerability, Pharmacokinetic, Food Effect, and Proof-of-Concept Study of Single and Multiple Doses of ORX489 in Healthy Adults
Lead sponsor
Centessa Pharmaceuticals (UK) Limited
Phase
Phase 1
Overall status
Recruiting
Start date
February 25, 2026
Completion date
June 30, 2027
Enrollment
212 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy adult male and female volunteers